|CCL 05.12.06 Protein Engineering, San Diego, CA|
From: chemistry-request at ccl.net
To: chemistry-request at ccl.net
Date: Sat Oct 22 17:34:14 2005
Subject: 05.12.06 Protein Engineering, San Diego, CA
Protein Engineering Defining the Next Generation of Biotherapeutics December 6-8, 2005 - San Diego Convention Center - San Diego, CA http://www.ibclifesciences.com/ IBC's Protein Engineering conference focuses on new protein pharmaceutical platforms and scientific strategies that need to be designed for efficient activity optimization against any specific target, and also for manufacturing, formulation and delivery. Presentations demonstrate how half-life, formulation, shelf-life, safety and non-immunogenicity requirements must be built into the product platform upfront so that every new product lead will have these properties, minimizing the need for additional testing in humans. Highlights include how: * Avidia uses avimers to create inhibitors to block IL-6 * Compound Therapeutics developed AdNectin as an agonist to VEGFR-2 * Molecular Partners AG developed DARPins for diagnostic and therapeutic applications * Dyax engineered Kunitz domain-based drug candidates that are in clinical and preclinical testing * Genencor constructed fusion proteins between fragments of tumor specific antibodies and -lactamase 2005 Scientific Advisory and Organizing Board James W. Larrick, M.D., Ph.D., Managing Director, Panorama Research Institute Andreas Plckthun, Ph.D., Professor of Biochemistry, Department of Biochemistry, University of Zrich, Switzerland Robert Balint, Ph.D., Founder and CEO, CytoDesign, Inc Bassil Dahiyat, Ph.D., President and Chief Executive Office, Xencor Willem 'Pim' Stemmer, PhD, Founder, Avidia, Inc., and Founder and VP R&D, Microproteins, Inc. Learn from World-Renowned Experts from these Organizations * Avidia Inc. * Biolex * Biorexis Pharmaceutical Corporation * Biosite Discovery * BioTech Studio LLC * Borean Pharma A/S, Denmark * Caltech * CEA, France * CSIRO Molecular and Health Technologies, Australia * Compound Therapeutics * CytoDesign, Inc * DiscoveRx Corp. * Dyax Corp. * EvoGenix, Australia * Genencor Intl., Inc. * Glycofi * Integrigen * Johns Hopkins University * Molecular Partners, Switzerland * Nektar * Panorama Research Institute * Syntonix Pharmaceuticals * The Carnegie Institution of Washington * The Scripps Research Institute * Trinity BioSystems, Inc. * University of California, San Francisco * University of Maryland Biotechnology Institute Center for Advanced Research in Biotechnology * University of Zrich, Switzerland * XencorNOTE THAT E-MAIL ADDRESSES HAVE BEEN MODIFIED!!!
All @ signs were changed to ]|[ to fight spam. Before you send e-mail, you need to change ]|[ to @
For example: change joe]|[big123comp.com to firstname.lastname@example.org
Please let colleagues know about conference listingts at Computational Chemistry List Conference Page at http://www.ccl.net/chemistry/a/conferences/.
Please help: If you find this conference list useful but you noticed some conference missing, please consider including it here by using the Conference Submission Page. It is free but your support is welcome. You will help others!!!
|Modified: Sat Oct 22 21:34:14 2005 GMT|
|Page accessed 6624 times since Sat Oct 22 21:34:14 2005 GMT|
Please help maintain CCL: If you found that your conference is listed here, please consider supporting CCL as a Supporting Member or use other Paid Services of CCL to ensure the continuation of this useful service. We cannot do it without your help.